Clinical implication of low estrogen receptor (ER-low) expression in breast cancer

Breast cancer is a heterogeneous disease, and the estrogen receptor (ER) remains the most important biomarker in breast oncology. Most guidelines set a positive expression threshold of 1% staining in immunohistochemistry (IHC) to define ER positivity. However, different expression levels may be asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinert, Tomás, Cascelli, Fanny, de Resende, Cristiano Augusto Andrade, Gonçalves, Aline Coelho, Godo, Vania Sanchez Prette, Barrios, Carlos Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729538/
https://www.ncbi.nlm.nih.gov/pubmed/36506043
http://dx.doi.org/10.3389/fendo.2022.1015388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729538/
https://www.ncbi.nlm.nih.gov/pubmed/36506043
http://dx.doi.org/10.3389/fendo.2022.1015388

Ejemplares similares